PRESS REVIEW

 

CheckmAb and Boehringer Ingelheim Collaborate to Develop Novel Immunotherapy for Cancer Patients

Read the article of the 22.03.2023

Cancer: Lombardy is fighting with advanced nanomedicine and molecules

Read the Italian Affaris article of the 30.11.2020

Here is CheckMab, the university spin-off that has raised over 10 million from individuals

Read the article Il Sole 24 Ore of15.03.2018